Available:*
Library | Item Barcode | Call Number | Material Type | Item Category 1 | Status |
---|---|---|---|---|---|
Searching... | 30000010245222 | RE551 A97 2010 | Open Access Book | Book | Searching... |
On Order
Summary
Summary
Discusses the Effect of Automated Assessment Programs on Health Care Provision
Diabetes is approaching pandemic numbers, and as an associated complication, diabetic retinopathy is also on the rise. Much about the computer-based diagnosis of this intricate illness has been discovered and proven effective in research labs. But, unfortunately, many of these advances have subsequently failed during transition from the lab to the clinic. So what is the best way to diagnose and treat retinopathy? Automated Image Detection of Retinal Pathology discusses the epidemiology of the disease, proper screening protocols, algorithm development, image processing, and feature analysis applied to the retina.
Conveys the Need for Widely Implemented Risk-Reduction Programs
Offering an array of informative examples, this book analyzes the use of automated computer techniques, such as pattern recognition, in analyzing retinal images and detecting diabetic retinopathy and its progression as well as other retinal-based diseases. It also addresses the benefits and challenges of automated health care in the field of ophthalmology. The book then details the increasing practice of telemedicine screening and other advanced applications including arteriolar-venous ratio, which has been shown to be an early indicator of cardiovascular, diabetes, and cerebrovascular risk.
Although tremendous advances have been made in this complex field, there are still many questions that remain unanswered. This book is a valuable resource for researchers looking to take retinal pathology to that next level of discovery as well as for clinicians and primary health care professionals that aim to utilize automated diagnostics as part of their health care program.
Author Notes
Herbert Jelinek, Charles Stuart University, Albury, New South Wales, Australia
Michael J. Cree, University of Waikato, Hamilton, New Zealand
Table of Contents
Preface | p. xiii |
Contributors | p. xvii |
1 Introduction | p. 1 |
1.1 Why Automated Image Detection of Retinal Pathology? | p. 1 |
1.1.1 The general clinical need | p. 2 |
1.1.2 Diabetes: A global problem | p. 2 |
1.1.3 Diabetic retinopathy | p. 2 |
1.1.4 Eye-screening for diabetic retinopathy | p. 3 |
1.1.5 Other retinal pathologies | p. 5 |
1.1.6 The retina as an indicator for disease elsewhere | p. 6 |
1.1.7 Research needs in automated retinopathy detection | p. 6 |
1.1.8 The engineering opportunity | p. 7 |
1.2 Automated Assessment of Retinal Eye Disease | p. 7 |
1.2.1 Automated microaneurysm detection in diabetic retinopathy | p. 8 |
1.2.2 Hemorrhages | p. 9 |
1.2.3 White lesion segmentation | p. 9 |
1.2.4 Localization of important markers | p. 10 |
1.2.5 Retinal vessel diameter changes in disease | p. 11 |
1.2.6 Retinal blood vessel segmentation | p. 11 |
1.2.7 Mathematical analysis of vessel patterns | p. 12 |
1.3 The Contribution of This Book | p. 13 |
2 Diabetic Retinopathy and Public Health | p. 27 |
2.1 Introduction | p. 27 |
2.2 The Pandemic of Diabetes and Its Complications | p. 28 |
2.3 Retinal Structure and Function | p. 29 |
2.4 Definition and Description | p. 35 |
2.5 Classification of Diabetic Retinopathy | p. 40 |
2.6 Differential Diagnosis of Diabetic Retinopathy | p. 40 |
2.7 Systemic Associations of Diabetic Retinopathy | p. 42 |
2.7.1 Duration of diabetes | p. 42 |
2.7.2 Type of diabetes | p. 42 |
2.7.3 Blood glucose control | p. 42 |
2.7.4 Blood pressure | p. 42 |
2.7.5 Serum lipids | p. 43 |
2.7.6 Renal disease | p. 43 |
2.7.7 Anemia | p. 43 |
2.7.8 Pregnancy | p. 43 |
2.7.9 Smoking | p. 43 |
2.8 Pathogenesis | p. 43 |
2.8.1 Hyperglycemia | p. 43 |
2.8.2 Hematological abnormalities | p. 44 |
2.8.3 Leukostasis and inflammation | p. 44 |
2.8.4 Growth factors | p. 44 |
2.8.5 Neurodegeneration | p. 45 |
2.9 Treatment | p. 45 |
2.9.1 Management of systemic associations | p. 45 |
2.9.2 Ocular treatments | p. 45 |
2.9.3 Investigational treatments | p. 46 |
2.10 Screening | p. 48 |
2.10.1 Methods of screening | p. 48 |
2.10.2 Frequency of screening | p. 54 |
2.10.3 Cost effectiveness of screening | p. 54 |
2.10.4 Access to care and screening | p. 54 |
2.11 Conclusion | p. 55 |
3 Detecting Retinal Pathology Automatically with Special Emphasis on Diabetic Retinopathy | p. 67 |
3.1 Historical Aside | p. 67 |
3.2 Approaches to Computer (Aided) Diagnosis | p. 68 |
3.3 Detection of Diabetic Retinopathy Lesions | p. 70 |
3.4 Detection of Lesions and Segmentation of Retinal Anatomy | p. 71 |
3.5 Detection and Staging of Diabetic Retinopathy: Pixel to Patient | p. 71 |
3.6 Directions for Research | p. 72 |
4 Finding a Role for Computer-Aided Early Diagnosis of Diabetic Retinopathy | p. 79 |
4.1 Mass Examinations of Eyes in Diabetes | p. 79 |
4.1.1 Motive for accurate early diagnosis of retinopathy | p. 80 |
4.1.2 Definition of screening | p. 81 |
4.1.3 Practical importance of the concept of screening | p. 81 |
4.1.4 Coverage and timely re-examination | p. 81 |
4.2 Developing and Defending a Risk Reduction Program | p. 82 |
4.2.1 Explaining why retinopathy is suitable for screening | p. 82 |
4.2.2 Understanding reasons for possible criticism | p. 83 |
4.2.3 Fulfilling criteria for screening tests | p. 83 |
4.2.4 Setting quality assurance standards | p. 84 |
4.2.5 Training and assessment | p. 84 |
4.3 Assessing Accuracy of a Diagnostic Test | p. 84 |
4.3.1 Predictive value, estimation, power | p. 85 |
4.3.2 Receiver operating characteristic curve | p. 87 |
4.3.3 Area under curve | p. 89 |
4.3.4 Covariates | p. 90 |
4.4 Improving Detection of Diabetic Retinopathy | p. 90 |
4.4.1 Improving work environment | p. 91 |
4.4.2 Going digital | p. 91 |
4.4.3 Obtaining clear images | p. 91 |
4.4.4 Avoiding loss of information | p. 92 |
4.4.5 Viewing images | p. 92 |
4.4.6 Ensuring accurate grading | p. 93 |
4.4.7 Organizing for success | p. 93 |
4.5 Measuring Outcomes of Risk Reduction Programs | p. 93 |
4.5.1 Reducing new blindness and visual impairment | p. 94 |
4.5.2 Counting people who lost vision | p. 94 |
4.5.3 Understanding the importance of visual impairment | p. 95 |
4.6 User Experiences of Computer-Aided Diagnosis | p. 96 |
4.6.1 Perceived accuracy of lesion detection | p. 97 |
4.6.2 Finding and reading evaluations of software for retinopathy diagnosis | p. 101 |
4.6.3 Opportunities and challenges for programmers | p. 102 |
4.7 Planning a Study to Evaluate Accuracy | p. 103 |
4.7.1 Getting help from a statistician | p. 103 |
4.7.2 Choosing a measurement scale | p. 103 |
4.7.3 Optimizing design | p. 104 |
4.7.4 Carrying out different phases of research | p. 108 |
4.7.5 An example from another field | p. 109 |
4.8 Conclusion | p. 110 |
4.9 Appendix: Measures of Binary Test Performance | p. 120 |
5 Retinal Markers for Early Detection of Eye Disease | p. 121 |
5.1 Abstract | p. 121 |
5.2 Introduction | p. 122 |
5.3 Nonproliferative Diabetic Retinopathy | p. 123 |
5.4 Chapter Overview | p. 124 |
5.5 Related Works on Identification of Retinal Exudates and the Optic Disc | p. 128 |
5.5.1 Exudate identification and classification | p. 128 |
5.5.2 Optic disc detection | p. 130 |
5.6 Preprocessing | p. 132 |
5.7 Pixel-Level Exudate Recognition | p. 134 |
5.8 Application of Pixel-Level Exudate Recognition on the Whole Retinal Image | p. 137 |
5.9 Locating the Optic Disc in Retinal Images | p. 139 |
5.9.1 Template matching | p. 141 |
5.9.2 Color morphology preprocessing | p. 141 |
5.9.3 Accurate localization of the optic disc-based snakes | p. 144 |
5.9.4 Optic disc localization results | p. 146 |
5.10 Conclusion | p. 148 |
6 Automated Microaneurysm Detection for Screening | p. 155 |
6.1 Characteristics of Microaneurysms and Dot-Hemorrhages | p. 155 |
6.2 History of Automated Microaneurysm Detection | p. 156 |
6.2.1 Early morphological approaches | p. 156 |
6.2.2 The "standard approach" to automated microaneurysm detection | p. 157 |
6.2.3 Extensions of the standard approach | p. 159 |
6.2.4 Other approaches | p. 162 |
6.2.5 General red lesion detection | p. 164 |
6.3 Microaneurysm Detection in Color Retinal Images | p. 165 |
6.4 The Waikato Automated Microaneurysm Detector | p. 167 |
6.4.1 Further comments on the use of color | p. 171 |
6.5 Issues for Microaneurysm Detection | p. 172 |
6.5.1 Image quality assessment | p. 172 |
6.5.2 Image compression implications | p. 173 |
6.5.3 Optic disc detection | p. 175 |
6.5.4 Meaningful comparisons of implementations | p. 175 |
6.6 Research Application of Microaneurysm Detection | p. 177 |
6.7 Conclusion | p. 178 |
7 Retinal Vascular Changes as Btomarkers of Systemic Cardiovascular Diseases | p. 185 |
7.1 Introduction | p. 185 |
7.2 Early Description of Retinal Vascular Changes | p. 186 |
7.3 Retinal Vascular Imaging | p. 187 |
7.3.1 Assessment of retinal vascular signs from retinal photographs | p. 187 |
7.3.2 Limitations in current retinal vascular imaging techniques | p. 187 |
7.4 Retina] Vascular Changes and Cardiovascular Disease | p. 189 |
7.4.1 Hypertension | p. 189 |
7.4.2 Stroke and cerebrovascular disease | p. 191 |
7.4.3 Coronary heart disease and congestive heart failure | p. 193 |
7.5 Retinal Vascular Changes and Metabolic Diseases | p. 194 |
7.5.1 Diabetes mellitus | p. 196 |
7.5.2 The metabolic syndrome | p. 196 |
7.5.3 Overweight and obesity | p. 197 |
7.6 Retinal Vascular Changes and Other Systemic Diseases | p. 197 |
7.6.1 Renal disease | p. 197 |
7.6.2 Atherosclerosis | p. 198 |
7.6.3 Inflammation and endothelial dysfunction | p. 198 |
7.6.4 Subclinical cardiac morphology | p. 200 |
7.7 Genetic Associations of Retinal Vascular Changes | p. 200 |
7.8 Conclusion | p. 201 |
7.A Appendix: Retinal Vessel Caliber Grading Protocol | p. 201 |
7.A.1 Grading an image | p. 202 |
7.A.2 Example of the grading process | p. 204 |
7.A.3 Obtaining results | p. 205 |
7.A.4 Saving data | p. 206 |
8 Segmentation of Retinal Vasculature Using Wavelets and Supervised Classification: Theory and Implementation | p. 221 |
8.1 Introduction | p. 221 |
8.2 Theoretical Background | p. 224 |
8.2.1 The 1-D CWT | p. 224 |
8.2.2 The 2-D CWT | p. 225 |
8.2.3 The 2-D Gabor wavelet | p. 228 |
8.2.4 Supervised classification | p. 229 |
8.2.5 Bayesian decision theory | p. 231 |
8.2.6 Bayesian Gaussian mixture model classifier | p. 231 |
8.2.7 K-nearest neighbor classifier | p. 233 |
8.2.8 Linear minimum squared error classifier | p. 234 |
8.3 Segmentation Using the 2-D Gabor Wavelet and Supervised Classification | p. 235 |
8.3.1 Preprocessing | p. 235 |
8.3.2 2-D Gabor wavelet features | p. 237 |
8.3.3 Feature normalization | p. 238 |
8.3.4 Supervised pixel classification | p. 239 |
8.3.5 Public image databases | p. 240 |
8.3.6 Experiments and settings | p. 241 |
8.3.7 ROC analysis | p. 242 |
8.4 Implementation and Graphical User Interface | p. 245 |
8.4.1 Overview | p. 245 |
8.4.2 Installation | p. 246 |
8.4.3 Command line interface | p. 246 |
8.4.4 Graphical user interface | p. 247 |
8.5 Experimental Results | p. 249 |
8.6 Conclusion | p. 258 |
8.6.1 Summary | p. 258 |
8.6.2 Future work | p. 258 |
9 Determining Retinal Vessel Widths and Detection of Width Changes | p. 269 |
9.1 Identifying Blood Vessels | p. 270 |
9.2 Vessel Models | p. 270 |
9.3 Vessel Extraction Methods | p. 271 |
9.4 Can's Vessel Extraction Algorithm | p. 271 |
9.4.1 Improving Can's algorithm | p. 272 |
9.4.2 Limitations of the modified Can algorithm | p. 275 |
9.5 Measuring Vessel Width | p. 276 |
9.6 Precise Boundary Detection | p. 278 |
9.7 Continuous Vessel Models with Spline-Based Ribbons | p. 279 |
9.7.1 Spline representation of vessels | p. 279 |
9.7.2 B-spline ribbons | p. 284 |
9.8 Estimation of Vessel Boundaries Using Snakes | p. 288 |
9.8.1 Snakes | p. 288 |
9.8.2 Ribbon snakes | p. 289 |
9.8.3 B-spline ribbon snake | p. 289 |
9.8.4 Cross section-based B-spline snakes | p. 292 |
9.8.5 B-spline ribbon snakes comparison | p. 293 |
9.9 Vessel Width Change Detection | p. 294 |
9.9.1 Methodology | p. 294 |
9.9.2 Change detection via hypothesis test | p. 296 |
9.9.3 Summary | p. 298 |
9.10 Conclusion | p. 298 |
10 Geometrical and Topological Analysis of Vascular Branches from Fundus Retinal Images | p. 305 |
10.1 Introduction | p. 305 |
10.2 Geometry of Vessel Segments and Bifurcations | p. 306 |
10.2.1 Arterial to venous diameter ratio | p. 306 |
10.2.2 Bifurcation geometry | p. 308 |
10.2.3 Vessel length to diameter ratios | p. 311 |
10.2.4 Tortuosity | p. 312 |
10.3 Vessel Diameter Measurements from Retinal Images | p. 312 |
10.3.1 The half-height method | p. 313 |
10.3.2 Double Gaussian fitting | p. 314 |
10.3.3 The sliding linear regression filter (SLRF) | p. 314 |
10.4 Clinical Findings from Retinal Vascular Geometry | p. 315 |
10.5 Topology of the Vascular Tree | p. 318 |
10.5.1 Strahler branching ratio | p. 321 |
10.5.2 Path length | p. 321 |
10.5.3 Number of edges | p. 321 |
10.5.4 Tree asymmetry index | p. 322 |
10.6 Automated Segmentation and Analysis of Retinal Fundus Images | p. 323 |
10.6.1 Feature extraction | p. 324 |
10.6.2 Region growing | p. 326 |
10.6.3 Analysis of binary images | p. 327 |
10.7 Clinical Findings from Retinal Vascular Topology | p. 328 |
10.8 Conclusion | p. 329 |
11 Tele-Diabetic Retinopathy Screening and Image-Based Clinical Decision Support | p. 339 |
11.1 Introduction | p. 339 |
11.2 Telemedicine | p. 339 |
11.2.1 Image capture | p. 340 |
11.2.2 Image resolution | p. 341 |
11.2.3 Image transmission | p. 342 |
11.2.4 Image compression | p. 342 |
11.3 Telemedicine Screening for Diabetic Retinopathy | p. 344 |
11.4 Image-Based Clinical Decision Support Systems | p. 346 |
11.5 Conclusion | p. 347 |
Index | p. 351 |